title: [Combined intratympanic and intravenous dexomethasone to control vertigo in Meniere disease].
abstract: OBJECTIVE
  To verify the result in the use of intratympanic corticosteroids, combined with intravenous, in patients with Meniere disease (MD).
  
  
  METHODS
  Ten patients with vertigo due to MD in stages 4-5 or 6 were included in the study. Combined intratympanic and intravenous dexamethasone was infiltrated. The number of episodes among the months 18 and 24 of treatment, comparing them with the number of episodes 6 months before treatment (according to the norms of the American committee for the hearing and the equilibrium, 1995) are studied.
  
  
  RESULTS
  All patients improved significantly. In one of them treatment was repeated after 6 months. A number of patients with hearing improvement were observed.
  
  
  CONCLUSIONS
  The use of combined dexamethasone may be useful to control vertigo due to MD, to avoid or to be a prior step to other more aggressive treatments.
authors.affiliation: Servicio de ORL, Hospital de Hellín, Albacete. fgpurrinhos@seorl.net
authors.forename: F J
authors.initials: FJ
authors.lastname: García-Purriños
authors.forename: E
authors.initials: E
authors.lastname: Ferri
authors.forename: A
authors.initials: A
authors.lastname: Rosell
authors.forename: J
authors.initials: J
authors.lastname: Calvo
mesh_terms: D000287:Administration, Topical; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D003907:Dexamethasone / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008575:Meniere Disease / Q000150:complications*; D008875:Middle Aged; D014432:Tympanic Membrane; D014717:Vertigo / Q000188:drug therapy* / Q000209:etiology*
chemical_list: D000893:Anti-Inflammatory Agents; D003907:Dexamethasone